Compare HRB & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRB | MMED |
|---|---|---|
| Founded | 1955 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.1B |
| IPO Year | 1994 | 2026 |
| Metric | HRB | MMED |
|---|---|---|
| Price | $38.22 | $14.21 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $41.00 | $22.56 |
| AVG Volume (30 Days) | ★ 2.5M | 793.7K |
| Earning Date | 05-06-2026 | 06-03-2026 |
| Dividend Yield | ★ 5.34% | N/A |
| EPS Growth | ★ 6.55 | N/A |
| EPS | ★ 3.38 | N/A |
| Revenue | ★ $3,159,931,000.00 | N/A |
| Revenue This Year | $4.39 | $15.99 |
| Revenue Next Year | $3.21 | $10.00 |
| P/E Ratio | $11.09 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.16 | $10.65 |
| 52 Week High | $58.21 | $17.86 |
| Indicator | HRB | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 57.41 | 64.64 |
| Support Level | $29.24 | $12.80 |
| Resistance Level | $39.84 | $15.80 |
| Average True Range (ATR) | 1.36 | 0.88 |
| MACD | -0.26 | 0.45 |
| Stochastic Oscillator | 38.26 | 78.19 |
H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.